Dapasel Tablet 5mg (Dapagliflozin Anhydrous Mixture)
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
MFDS item code 202101088 · Approved 2021.02.04
This product's status changed to Approval withdrawn on 2025.08.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improves blood glucose control in patients with type 2 diabetes mellitus
This medication is used alongside diet and exercise regimens to help control blood sugar levels in patients with type 2 diabetes. It can be taken alone, but if blood sugar control is challenging, it may be used in combination with other diabetes medications such as metformin, sulfonylureas, insulin, and sitagliptin. Especially when existing treatments do not adequately control blood sugar levels, this drug can be added to enhance efficacy. Therefore, this medication plays a very important role in improving blood sugar control.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous history of diabetes drug treatment, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in patients with allergies to its active ingredients or excipients. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with lactose intolerance should not use this medication due to the presence of lactose anhydrous. Patients undergoing dialysis should not take this medication. Patients with reduced fluid volume or compromised kidney function should use this medication cautiously, and renal function and blood pressure should be closely monitored before and after administration. Caution is especially needed for elderly patients or those on diuretics, as they are at higher risk for hypotension or volume depletion. This medication contains certain dyes, so patients with allergies to these components should take it cautiously. This medication may cause genital infections or urinary tract infections; if symptoms occur, seek immediate treatment. There is a risk of hypoglycemia, so when used in conjunction with insulin or sulfonylurea medications, dosage adjustments may be necessary. Dehydration or hypotensive symptoms may arise due to reduced fluid volume, so adequate fluid intake and monitoring of condition are essential. Diabetic ketoacidosis may occur, so if symptoms such as nausea, vomiting, abdominal pain, or breathing difficulties arise, consult a healthcare professional immediately. This medication may affect kidney function; therefore, patients with reduced renal function require regular check-ups. Serious infections like perineal necrosis have been rarely reported, so if there is pain or abnormal symptoms in that area, seek immediate treatment. Pregnant women or those planning to become pregnant should avoid this medication, and breastfeeding women should also not take it. The safety of this medication has not been established in pediatric patients; thus, it should not be used in children. In case of overdose, there is no specific antidote, and appropriate treatment should be based on symptoms, with attention paid to dehydration or hypotensive symptoms. This medication does not significantly impact driving or operating machinery but caution is needed as hypoglycemic symptoms may occur. When storing, keep it out of reach of children and store in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is recommended to store at room temperature between 1 degree and 30 degrees. This storage method will safely maintain the medication's efficacy.
Yellow, biconvex, round film-coated tablet
28 tablets/box [14 tablets/PTP X 2, 7 tablets/PTP X 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
International Pharmaceuticals Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Sinil Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.